Use of dual intracoronary scintigraphy with thallium-201 and technetium-99m pyrophosphate to predict improvement in left ventricular wall motion immediately after intracoronary thrombolysis in acute myocardial infarction.
D000328:Adult; D000368:Aged; D003331:Coronary Vessels; D011756:Diphosphates; D004298:Dopamine / Q000627:therapeutic use; D005260:Female; D006321:Heart / Q000000981:diagnostic imaging; D006801:Humans; D007269:Injections, Intra-Arterial; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction; D009203:Myocardial Infarction / Q000000981:diagnostic imaging* / Q000188:drug therapy; D005996:Nitroglycerin / Q000627:therapeutic use; D011868:Radioisotopes; D011877:Radionuclide Imaging; D013300:Streptokinase / Q000008:administration & dosage / Q000627:therapeutic use*; D013318:Stroke Volume; D013667:Technetium; D016698:Technetium Tc 99m Pyrophosphate; D013793:Thallium
D011756:Diphosphates; D011868:Radioisotopes; D016698:Technetium Tc 99m Pyrophosphate; D013667:Technetium; D013793:Thallium; D013300:Streptokinase; D005996:Nitroglycerin; D004298:Dopamine